ConductScience.org, home

Paper37489366

Detection of Antibody-Dependent Cell-Mediated Cytotoxicity-Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization.

Cruz Amaya J and 4 others. Antibodies (Basel), 2023. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Detection of Antibody-Dependent Cell-Mediated Cytotoxicity-Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization. Papers, record 37489366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37489366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Detection of Antibody-Dependent Cell-Mediated Cytotoxicity-Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization.
PubMed
Journal
Antibodies (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.21
iCite
Revised in PubMed
2024-01-12
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cruz Amaya JJudithhttps://orcid.org/0009-0003-3952-8603
2Walcheck BBrucehttps://orcid.org/0000-0003-1933-3887
3Smith-Gagen JJulie
4Lombardi VCVincent Chttps://orcid.org/0000-0003-4474-8662
5Hudig DDorothyhttps://orcid.org/0000-0001-5952-208X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA203348NCI NIH HHSUnited StatesR01CA203348PubMed and NIHNIH RePORTER
GM103440NIH HHSUnited StatesP20GM103440PubMed and NIHNIH RePORTER
GM110767NIH HHSUnited StatesP30GM110767PubMed and NIHNIH RePORTER
RO1CA203348NIH HHSUnited StatesR01CA203348PubMed and NIHNIH RePORTER

Download CSV of grants

References69

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14966657Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.Immunology1968https://conductscience.org/library/papers/4966657PubMed
221296976Mechanism of action of type II, glycoengineered, anti-CD20 monoclonal antibody GA101 in B-chronic lymphocytic leukemia whole blood assays in comparison with rituximab and alemtuzumab.J Immunol2011https://conductscience.org/library/papers/21296976PubMed
327161864Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood.J Proteome Res2016https://conductscience.org/library/papers/27161864PubMed
429592963Single Degranulations in NK Cells Can Mediate Target Cell Killing.J Immunol2018https://conductscience.org/library/papers/29592963PubMed
528163018Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.J Immunol Methods2017https://conductscience.org/library/papers/28163018PubMed
623487023NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17).Blood2013https://conductscience.org/library/papers/23487023PubMed
720536565Once a killer, always a killer: from cytotoxic T cell to memory cell.Immunol Rev2010https://conductscience.org/library/papers/20536565PubMed
836513064Antibody effector functions are associated with protection from respiratory syncytial virus.Cell2022https://conductscience.org/library/papers/36513064PubMed
924704820Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - impact of effector cells.J Immunol Methods2014https://conductscience.org/library/papers/24704820PubMed
106265471Differential effect of monensin on enveloped viruses that form at distinct plasma membrane domains.J Cell Biol1981https://conductscience.org/library/papers/6265471PubMed
111939168Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking.J Biol Chem1991https://conductscience.org/library/papers/1939168PubMed
1223319732Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.J Immunol2013https://conductscience.org/library/papers/23319732PubMed
1312144129CD107a (LAMP-1) and CD107b (LAMP-2).J Biol Regul Homeost Agents2002https://conductscience.org/library/papers/12144129PubMed
142022921Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes.J Exp Med1991https://conductscience.org/library/papers/2022921PubMed
152032551Effects of Brefeldin A on the Golgi complex, endoplasmic reticulum and viral envelope glycoproteins in murine erythroleukemia cells.Eur J Cell Biol1991https://conductscience.org/library/papers/2032551PubMed
1629903548Antibody glycosylation in inflammation, disease and vaccination.Semin Immunol2018https://conductscience.org/library/papers/29903548PubMed
1723851282Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functions.Methods2014https://conductscience.org/library/papers/23851282PubMed
1823006327Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity.J Clin Invest2012https://conductscience.org/library/papers/23006327PubMed
1930016589Antibody Fucosylation Lowers the FcγRIIIa/CD16a Affinity by Limiting the Conformations Sampled by the N162-Glycan.ACS Chem Biol2018https://conductscience.org/library/papers/30016589PubMed
2034349345An NK cell line (NK92-41BB) expressing high levels of granzyme is engineered to express the high affinity chimeric genes CD16/CAR.Cytotechnology2021https://conductscience.org/library/papers/34349345PubMed

See all 69 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
41961075Targeting ST3GAL1 to downregulate ligands for the glycoimmune checkpoint Siglec-7 and reverse immune escape in hepatocellular carcinoma.Cancer Immunol Immunother2026https://conductscience.org/library/papers/41961075PubMed
40177643Fc gamma receptor polymorphisms in antibody therapy: implications for bioassay development to enhance product quality.Antib Ther2025https://conductscience.org/library/papers/40177643PubMed

Download CSV of cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37489366

GET https://conductscience.org/api/papers/v1/37489366/references?page=2